Back to Trades
Total Value
$NaN
Filing Date
Jul 17, 2026
1 transactions
Trade Summary
On Jul 10, 2026, RA CAPITAL MANAGEMENT, L.P., Insider, reported $NaN of Inhibikase Therapeutics, Inc. (IKT) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Inhibikase Therapeutics, Inc.
- Ticker Symbol
- IKT
- CIK
- 0001750149
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 10, 2026
- Accession Number
- 0001231919-26-000769
- Form Type
- 3
Want live alerts when RA CAPITAL MANAGEMENT, L.P. trades again?
Download Insider Trades to track IKT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- (F2)Held directly by the Fund.